Journal articleEur J Nucl Med Mol Imaging2019

18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancer.

DOI 10.1007/s00259-019-04295-7 ↗ Europe PMC, retrieved 5 November 2026

Journal: Eur J Nucl Med Mol Imaging
Published: 8 March 2019
Citations: 16

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 1

Its registry lists this paper as results18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy NCT01806675 ↗

The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.